Insufficient scRNA-seq data for expression of E2F1 at single-cell level.
Insufficient scRNA-seq data for expression of E2F1 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
ovary | 99% | 413.63 | 179 / 180 | 99% | 49.21 | 425 / 430 |
esophagus | 99% | 430.33 | 1434 / 1445 | 98% | 32.37 | 179 / 183 |
skin | 96% | 655.77 | 1744 / 1809 | 98% | 49.71 | 462 / 472 |
stomach | 99% | 360.01 | 354 / 359 | 95% | 40.75 | 273 / 286 |
intestine | 98% | 380.35 | 947 / 966 | 96% | 39.77 | 504 / 527 |
bladder | 100% | 305.76 | 21 / 21 | 94% | 44.50 | 472 / 504 |
lung | 98% | 488.06 | 567 / 578 | 92% | 31.69 | 1061 / 1155 |
uterus | 85% | 139.21 | 145 / 170 | 98% | 72.58 | 452 / 459 |
breast | 90% | 188.13 | 413 / 459 | 89% | 31.67 | 999 / 1118 |
brain | 98% | 530.04 | 2590 / 2642 | 81% | 24.87 | 570 / 705 |
adrenal gland | 100% | 630.06 | 258 / 258 | 69% | 19.12 | 158 / 230 |
thymus | 64% | 91.21 | 418 / 653 | 74% | 15.48 | 447 / 605 |
prostate | 97% | 248.69 | 237 / 245 | 29% | 4.50 | 147 / 502 |
pancreas | 27% | 39.76 | 88 / 328 | 78% | 15.32 | 139 / 178 |
liver | 31% | 114.86 | 69 / 226 | 71% | 23.73 | 287 / 406 |
lymph node | 0% | 0 | 0 / 0 | 100% | 68.52 | 29 / 29 |
spleen | 100% | 602.07 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 90.46 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 28.18 | 1 / 1 |
peripheral blood | 94% | 950.63 | 877 / 929 | 0% | 0 | 0 / 0 |
adipose | 86% | 190.23 | 1038 / 1204 | 0% | 0 | 0 / 0 |
kidney | 39% | 91.39 | 35 / 89 | 39% | 5.79 | 352 / 901 |
muscle | 66% | 92.45 | 529 / 803 | 0% | 0 | 0 / 0 |
blood vessel | 64% | 105.95 | 861 / 1335 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 64% | 8.48 | 51 / 80 |
heart | 44% | 67.30 | 377 / 861 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0071466 | Biological process | cellular response to xenobiotic stimulus |
GO_0048146 | Biological process | positive regulation of fibroblast proliferation |
GO_1990086 | Biological process | lens fiber cell apoptotic process |
GO_0070345 | Biological process | negative regulation of fat cell proliferation |
GO_0030900 | Biological process | forebrain development |
GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
GO_0010628 | Biological process | positive regulation of gene expression |
GO_0043276 | Biological process | anoikis |
GO_0045599 | Biological process | negative regulation of fat cell differentiation |
GO_2000045 | Biological process | regulation of G1/S transition of mitotic cell cycle |
GO_0048255 | Biological process | mRNA stabilization |
GO_0000122 | Biological process | negative regulation of transcription by RNA polymerase II |
GO_0006351 | Biological process | DNA-templated transcription |
GO_0045893 | Biological process | positive regulation of DNA-templated transcription |
GO_0072332 | Biological process | intrinsic apoptotic signaling pathway by p53 class mediator |
GO_0008630 | Biological process | intrinsic apoptotic signaling pathway in response to DNA damage |
GO_0006355 | Biological process | regulation of DNA-templated transcription |
GO_0043392 | Biological process | negative regulation of DNA binding |
GO_0043065 | Biological process | positive regulation of apoptotic process |
GO_0045892 | Biological process | negative regulation of DNA-templated transcription |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0000077 | Biological process | DNA damage checkpoint signaling |
GO_0035189 | Cellular component | Rb-E2F complex |
GO_0005813 | Cellular component | centrosome |
GO_0032991 | Cellular component | protein-containing complex |
GO_0005654 | Cellular component | nucleoplasm |
GO_0090575 | Cellular component | RNA polymerase II transcription regulator complex |
GO_0005737 | Cellular component | cytoplasm |
GO_0000785 | Cellular component | chromatin |
GO_0005634 | Cellular component | nucleus |
GO_0003677 | Molecular function | DNA binding |
GO_0000978 | Molecular function | RNA polymerase II cis-regulatory region sequence-specific DNA binding |
GO_0140297 | Molecular function | DNA-binding transcription factor binding |
GO_0000981 | Molecular function | DNA-binding transcription factor activity, RNA polymerase II-specific |
GO_0060090 | Molecular function | molecular adaptor activity |
GO_0000987 | Molecular function | cis-regulatory region sequence-specific DNA binding |
GO_0043565 | Molecular function | sequence-specific DNA binding |
GO_1990837 | Molecular function | sequence-specific double-stranded DNA binding |
GO_0003700 | Molecular function | DNA-binding transcription factor activity |
GO_0001216 | Molecular function | DNA-binding transcription activator activity |
GO_0046983 | Molecular function | protein dimerization activity |
GO_0005515 | Molecular function | protein binding |
Gene name | E2F1 |
Protein name | Transcription factor E2F1 (E2F-1) (PBR3) (Retinoblastoma-associated protein 1) (RBAP-1) (Retinoblastoma-binding protein 3) (RBBP-3) (pRB-binding protein E2F-1) |
Synonyms | RBBP3 |
Description | FUNCTION: Transcription activator that binds DNA cooperatively with DP proteins through the E2 recognition site, 5'-TTTC[CG]CGC-3' found in the promoter region of a number of genes whose products are involved in cell cycle regulation or in DNA replication . The DRTF1/E2F complex functions in the control of cell-cycle progression from G1 to S phase . E2F1 binds preferentially RB1 in a cell-cycle dependent manner . It can mediate both cell proliferation and TP53/p53-dependent apoptosis . Blocks adipocyte differentiation by binding to specific promoters repressing CEBPA binding to its target gene promoters . Directly activates transcription of PEG10 . Positively regulates transcription of RRP1B . . |
Accessions | Q01094 ENST00000343380.6 |